Jeffrey H. Burbank is CEO at NxStage Medical, Inc. (NXTM). They have made 14 open-market trades across 1 company since 2006, most recently 2026-05-18.
CIK 0001341411
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NXTM | SELL | 2017-04-20 | 2017-04-21 | $27.28 | $82K | -3.9% | -23.7% | -13.7% |
| NXTM | SELL | 2017-04-19 | 2017-04-20 | $26.65 | $80K | +8.2% | -23.4% | -13.6% |
| NXTM | SELL | 2017-03-22 | 2017-03-23 | $27.42 | $82K | +0.3% | +9.6% | -12.1% |
| NXTM | SELL | 2017-03-21 | 2017-03-22 | $27.72 | $83K | -1.2% | +3.6% | -14.3% |
| NXTM | SELL | 2017-02-23 | 2017-02-24 | $28.97 | $217K | -5.9% | -7.4% | -21.9% |
| NXTM | SELL | 2017-02-22 | 2017-02-23 | $29.01 | $218K | -4.6% | -7.0% | -24.0% |
| NXTM | SELL | 2017-01-18 | 2017-01-18 | $27.63 | $207K | -4.8% | +5.2% | -4.1% |
| NXTM | SELL | 2017-01-17 | 2017-01-17 | $27.52 | $206K | -3.1% | +6.8% | -5.6% |
| NXTM | SELL | 2016-12-14 | 2016-12-14 | $25.68 | $193K | +0.3% | +8.5% | +7.1% |
| NXTM | SELL | 2016-12-13 | 2016-12-13 | $25.42 | $191K | -0.4% | +8.2% | +9.1% |
| NXTM | SELL | 2016-11-23 | 2016-11-23 | $24.01 | $180K | -2.6% | +0.5% | +15.1% |
| NXTM | SELL | 2016-11-22 | 2016-11-22 | $25.51 | $191K | +1.2% | +3.9% | +21.9% |
| NXTM | SELL · 10b5-1 | 2015-12-10 | 2015-12-11 | $18.94 | $176K | -11.6% | -7.4% | -29.3% |
| NXTM | SELL · 10b5-1 | 2015-11-10 | 2015-11-12 | $20.75 | $208K | -11.6% | -2.1% | -29.5% |
| NXTM | SELL · 10b5-1 | 2015-11-09 | 2015-11-09 | $20.32 | $203K | -11.6% | -2.1% | -19.6% |
| NXTM | SELL · 10b5-1 | 2015-10-16 | 2015-10-16 | $15.59 | $156K | -11.6% | -2.1% | -11.5% |
| NXTM | SELL · 10b5-1 | 2015-10-15 | 2015-10-15 | $14.98 | $150K | -11.6% | -2.1% | -11.6% |
| NXTM | SELL · 10b5-1 | 2015-09-17 | 2015-09-17 | $16.18 | $162K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2015-09-16 | 2015-09-16 | $15.99 | $160K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2015-08-13 | 2015-08-17 | $18.31 | $183K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2015-08-12 | 2015-08-14 | $18.03 | $180K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2015-06-17 | 2015-06-19 | $15.56 | $311K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL | 2015-05-13 | 2016-04-15 | $16.21 | $162K | +6.3% | +19.3% | +44.4% |
| NXTM | SELL · 10b5-1 | 2015-05-12 | 2015-05-13 | $16.44 | $164K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL · 10b5-1 | 2015-04-17 | 2015-04-21 | $18.08 | $181K | -11.6% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.